Argenx
ARGX
#525
Rank
$38.98 B
Marketcap
$647.39
Share price
1.07%
Change (1 day)
77.60%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: $38.98 Billion USD

As of January 2025 Argenx has a market cap of $38.98 Billion USD. This makes Argenx the world's 525th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025$38.98 B4.1%
2024$37.45 B65.96%
2023$22.56 B7.67%
2022$20.95 B13.96%
2021$18.39 B31.15%
2020$14.02 B103.85%
2019$6.87 B96.18%
2018$3.50 B74.88%
2017$2.00 B
2014$0.14 B

End of Day market cap according to different sources

On Jan 21st, 2025 the market cap of Argenx was reported to be:

$39.70 Billion USD
by Yahoo Finance info icon info icon
$39.70 Billion USD
by CompaniesMarketCap info icon info icon
$38.32 Billion USD
by Nasdaq info icon info icon